Drug Manufacturing

Amyris to buy women’s wellness firm MenoLabs

Synthetic biotechnology company Amyris has agreed to acquire MenoLabs, a menopause symptoms treatment company.

Pfizer and Biohaven close collaboration agreements

Pfizer has completed the collaboration transaction with Biohaven Pharmaceuticals to obtain rights to market the latter’s rimegepant and zavegepant outside of the US.

Ovid signs license deal with AstraZeneca to expand epilepsy drug pipeline

Ovid Therapeutics has signed a license agreement with AstraZeneca for a library of early-stage small molecules that target the KCC2 transporter.

Ascletis expands ritonavir oral tablets production amid Covid-19 surge

Ascletis Pharma is expanding the production of ritonavir oral tablets as well as the oral direct-acting antiviral R&D pipeline to treat SARS-CoV-2 virus amid the recent surge in Covid-19 cases.

Texas Children’s Hospital to launch protein sub-unit Covid-19 vaccine

Texas Children's Hospital and Baylor College of Medicine are set to launch Corbevax, a protein sub-unit Covid-19 vaccine in India, with plans to roll out in other underserved countries later.

Pfizer to deliver 2.5 million additional doses of Covid-19 pill to UK

Pfizer has signed an agreement to deliver an additional 2.5 million treatment courses of its investigational Covid-19 pill Paxlovid to the UK.

Novo Nordisk to invest in new production facilities at Danish plant

Novo Nordisk has announced plans to make more than $2.58bn (DKK17bn) investment to expand its manufacturing facilities in Kalundborg, Denmark.

Valneva, IDT Biologika partner to produce Covid-19 vaccines

French company Valneva and IDT Biologika have partnered to manufacture the former’s inactivated vaccine candidate, VLA2001, for Covid-19.

AzurRx to acquire First Wave Bio for $229m

US-based biopharmaceutical firm AzurRx BioPharma has agreed to acquire clinical-stage biotechnology company First Wave Bio in a stock-and-cash deal valued at $229m.